107
Participants
Start Date
September 11, 2014
Primary Completion Date
October 1, 2019
Study Completion Date
December 31, 2026
Acalabrutinib (ACP-196)
Acalabrutinib (ACP-196)
Research Site, New York
Research Site, Athens
Research Site, Marseille
Research Site, Aurillac
Research Site, Washington D.C.
Research Site, Milan
Research Site, Novara
Research Site, Toulouse
Research Site, Montpellier
Research Site, Rennes
Research Site, Salamanca
Research Site, Nashville
Research Site, Bologna
Research Site, Nantes
Research Site, Reims
Research Site, Vandœuvre-lès-Nancy
Research Site, Minneapolis
Research Site, Clermond Ferrand
Research Site, Pierre-Bénite
Research Site, Paris
Research Site, Paris
Research Site, Bedford
Research Site, Houston
Research Site, Austin
Research Site, Aurora
Research Site, Poitiers
Research Site, Santa Barbara
Research Site, Vancouver
Research Site, Amsterdam
Research Site, Utrecht
Research Site, Bournemouth
Research Site, Leeds
Research Site, Leicester
Research Site, London
Research Site, London
Research Site, Oxford
Research Site, Plymouth
Research Site, Southampton
Lead Sponsor
Acerta Pharma BV
INDUSTRY